Finoriq research workspace
ILLUMINA, INC. (ILMN) SEC Filings & Filing Highlights
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in. Review ILMN SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
- Company
- ILLUMINA, INC. (ILMN)
- Ticker
- ILMN
- Market Cap
- $28.1B
- Latest Price
- $185.69
- Industry
- Medical Devices
ILLUMINA, INC. (ILMN) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for ILLUMINA, INC. (ILMN).
| Event | Form | Date |
|---|---|---|
| On June 16, 2026, the Board of Directors (the “Board”) of Illumina, Inc. (the “Company”) increa...On June 16, 2026, the Board of Directors (the “Board”) of Illumina, Inc. (the “Company”) increased the size of the Board from nine to ten m... | 8-K5.02 | 2026-06-23 |
| The 2026 annual meeting of stockholders of Illumina, Inc. was held on May 21, 2026, at which th...The 2026 annual meeting of stockholders (the "Annual Meeting") of Illumina, Inc. (the "Company") was held on May 21, 2026, at which the Com... | 8-K5.07 | 2026-05-26 |
| Table of ContentsOn April 28, 2026, the Company’s Board of Directors authorized a new share repurchase program for up to $1.5 billion of the Company’s commo... | 8-K8.01 | 2026-04-30 |
| Table of ContentsOn April 30, 2026, Illumina, Inc. (the “Company”) issued a press release announcing financial results for the first quarter ended March 29,... | 8-K2.02 | 2026-04-30 |
| Illumina Announces Changes to Board of DirectorsIllumina Announces Changes to Board of Directors | 8-K7.01 | 2026-04-02 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.